Genscript Biotech Corporation

SEHK:1548 Stock Report

Market Cap: HK$19.5b

Genscript Biotech Past Earnings Performance

Past criteria checks 0/6

Genscript Biotech's earnings have been declining at an average annual rate of -23.2%, while the Life Sciences industry saw earnings growing at 22.4% annually. Revenues have been growing at an average rate of 25.7% per year.

Key information

-23.2%

Earnings growth rate

-21.2%

EPS growth rate

Life Sciences Industry Growth41.4%
Revenue growth rate25.7%
Return on equity-17.4%
Net Margin-11.4%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Slammed 28% Genscript Biotech Corporation (HKG:1548) Screens Well Here But There Might Be A Catch

Jun 05
Slammed 28% Genscript Biotech Corporation (HKG:1548) Screens Well Here But There Might Be A Catch

A Look At The Fair Value Of Genscript Biotech Corporation (HKG:1548)

May 10
A Look At The Fair Value Of Genscript Biotech Corporation (HKG:1548)

Is Genscript Biotech (HKG:1548) A Risky Investment?

Apr 13
Is Genscript Biotech (HKG:1548) A Risky Investment?

Investors Appear Satisfied With Genscript Biotech Corporation's (HKG:1548) Prospects As Shares Rocket 29%

Mar 13
Investors Appear Satisfied With Genscript Biotech Corporation's (HKG:1548) Prospects As Shares Rocket 29%

Genscript Biotech Corporation (HKG:1548) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Jan 26
Genscript Biotech Corporation (HKG:1548) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny

Is Genscript Biotech (HKG:1548) A Risky Investment?

Nov 21
Is Genscript Biotech (HKG:1548) A Risky Investment?

Is Genscript Biotech (HKG:1548) A Risky Investment?

Aug 22
Is Genscript Biotech (HKG:1548) A Risky Investment?

Time To Worry? Analysts Just Downgraded Their Genscript Biotech Corporation (HKG:1548) Outlook

Apr 04
Time To Worry? Analysts Just Downgraded Their Genscript Biotech Corporation (HKG:1548) Outlook

Analysts Have Been Trimming Their Genscript Biotech Corporation (HKG:1548) Price Target After Its Latest Report

Apr 03
Analysts Have Been Trimming Their Genscript Biotech Corporation (HKG:1548) Price Target After Its Latest Report

Is Genscript Biotech (HKG:1548) A Risky Investment?

Apr 02
Is Genscript Biotech (HKG:1548) A Risky Investment?

Genscript Biotech Corporation (HKG:1548) Shares Could Be 25% Below Their Intrinsic Value Estimate

Feb 07
Genscript Biotech Corporation (HKG:1548) Shares Could Be 25% Below Their Intrinsic Value Estimate

What Is Genscript Biotech Corporation's (HKG:1548) Share Price Doing?

Dec 14
What Is Genscript Biotech Corporation's (HKG:1548) Share Price Doing?

Genscript Biotech Corporation (HKG:1548) Shares Could Be 22% Below Their Intrinsic Value Estimate

Nov 09
Genscript Biotech Corporation (HKG:1548) Shares Could Be 22% Below Their Intrinsic Value Estimate

Is Genscript Biotech (HKG:1548) Using Debt Sensibly?

Oct 22
Is Genscript Biotech (HKG:1548) Using Debt Sensibly?

Health Check: How Prudently Does Genscript Biotech (HKG:1548) Use Debt?

Apr 03
Health Check: How Prudently Does Genscript Biotech (HKG:1548) Use Debt?

Does Genscript Biotech (HKG:1548) Have A Healthy Balance Sheet?

Oct 03
Does Genscript Biotech (HKG:1548) Have A Healthy Balance Sheet?

Is It Time To Consider Buying Genscript Biotech Corporation (HKG:1548)?

Sep 07
Is It Time To Consider Buying Genscript Biotech Corporation (HKG:1548)?

Estimating The Fair Value Of Genscript Biotech Corporation (HKG:1548)

Aug 16
Estimating The Fair Value Of Genscript Biotech Corporation (HKG:1548)

Is It Time To Consider Buying Genscript Biotech Corporation (HKG:1548)?

Jun 03
Is It Time To Consider Buying Genscript Biotech Corporation (HKG:1548)?

Is Genscript Biotech Corporation (HKG:1548) Trading At A 49% Discount?

May 13
Is Genscript Biotech Corporation (HKG:1548) Trading At A 49% Discount?

Is Genscript Biotech (HKG:1548) Using Debt In A Risky Way?

Apr 16
Is Genscript Biotech (HKG:1548) Using Debt In A Risky Way?

Could The Genscript Biotech Corporation (HKG:1548) Ownership Structure Tell Us Something Useful?

Mar 20
Could The Genscript Biotech Corporation (HKG:1548) Ownership Structure Tell Us Something Useful?

Are Insiders Selling Genscript Biotech Corporation (HKG:1548) Stock?

Feb 13
Are Insiders Selling Genscript Biotech Corporation (HKG:1548) Stock?

Did The Underlying Business Drive Genscript Biotech's (HKG:1548) Lovely 753% Share Price Gain?

Jan 09
Did The Underlying Business Drive Genscript Biotech's (HKG:1548) Lovely 753% Share Price Gain?

Could The Genscript Biotech Corporation (HKG:1548) Ownership Structure Tell Us Something Useful?

Dec 05
Could The Genscript Biotech Corporation (HKG:1548) Ownership Structure Tell Us Something Useful?

Revenue & Expenses Breakdown

How Genscript Biotech makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SEHK:1548 Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 23840-95393433
30 Sep 23773-140383426
30 Jun 23707-185374420
31 Mar 23667-206363405
31 Dec 22626-227352390
30 Sep 22598-315354375
30 Jun 22570-403356361
31 Mar 22530-381330360
31 Dec 21490-359303358
30 Sep 21483-265270341
30 Jun 21454-183235323
31 Mar 21422-194216293
31 Dec 20391-205197263
30 Sep 20354-194171251
30 Jun 20318-183146239
31 Mar 20296-140136212
31 Dec 19273-97126186
30 Sep 19257-59112148
30 Jun 19241-2298109
31 Mar 1923608992
31 Dec 18231217974
30 Sep 18216247258
30 Jun 18201276541
31 Mar 18177265630
31 Dec 17153264718
30 Sep 17139274811
30 Jun 1712528495
31 Mar 1712027502
31 Dec 1611526510
30 Sep 1610726500
30 Jun 169925480
31 Mar 169321470
31 Dec 158718460
30 Sep 158213430
30 Jun 15788390
31 Mar 15747380
31 Dec 14706370
31 Dec 13606290

Quality Earnings: 1548 is currently unprofitable.

Growing Profit Margin: 1548 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 1548 is unprofitable, and losses have increased over the past 5 years at a rate of 23.2% per year.

Accelerating Growth: Unable to compare 1548's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 1548 is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (0.7%).


Return on Equity

High ROE: 1548 has a negative Return on Equity (-17.37%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.